Upexi (UPXI) priced a secondary stock offering Monday to raise $100 million by selling 43.9 million shares at $2.28 each.
The stock soared more than sixfold as intraday volume topped 89.5 million shares versus the daily average of almost 140,000.
ReShape Lifesciences (RSLS) said the US Patent and Trademark Office awarded a notice of allowance for its proprietary diabetes neuromodulation technology, under patent application, titled high-frequency low duty cycle patterns for neural regulation.
The stock surged 33% as volume topped 142.3 million versus the daily average of about 13.1 million.
Forge Global Holdings (FRGE) shares rose 38%, a session after the company made a nonbinding offer to acquire privately held asset manager Accuidity.
Volume topped 635,000 versus the daily average of almost 69,000.
Price: 14.63, Change: +12.36, Percent Change: +544.27
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。